Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (101-110 of 490) with videos related to

Pageof 49
Sort By:
Expert Review of Clinical Pharmacology|March 3, 2026
Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosaSophie Andreou, Sera Sarsam, Dédée F Murrell
Clinics in Dermatology|December 6, 2011
Inherited epidermolysis bullosa: new diagnostic criteria and classificationLizbeth R A Intong, Dédée F Murrell
NPJ Digital Medicine|August 26, 2024
Digital twins in dermatology, current status, and the road aheadHossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell
Frontiers in Medicine|November 21, 2022
Bullous pemphigoid-What do we know about the most recent therapies?Faith A P Zeng, Dedee F Murrell
JAAD International|October 24, 2025
Ofatumumab for the management of refractory pemphigus vulgaris: A case seriesSera Sarsam, Ailin He, Dédée F Murrell
International Journal of Women'S Dermatology|September 4, 2018
Pemphigoid gestationis and intravenous immunoglobulin therapyAnes Yang, Elizabeth Uhlenhake, Dedee F Murrell
Journal of the American Academy of Dermatology|March 19, 2019
Patients left behind: Rare dermatologic conditions miss the orphan drug development boomAfton Chavez, Greg Licholai, Dédée F Murrell
The Australasian Journal of Dermatology|May 24, 2025
The Efficacy of Using Oral Sodium Cromoglycate for Controlling Epidermolysis Bullosa-Related PruritusSera Sarsam, Annabel Stevenson, Dédée F Murrell
Dermatologic Clinics|May 8, 2010
How to take skin biopsies for epidermolysis bullosaLizbeth Ruth A Intong, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Pemphigoid gestationis: pathogenesis and clinical featuresLizbeth R A Intong, Dédée F Murrell
Pageof 49

Showing results (101-110 of 490) with videos related to

Sort By:
Pageof 49
Expert Review of Clinical Pharmacology|March 3, 2026
Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosaSophie Andreou, Sera Sarsam, Dédée F Murrell
Clinics in Dermatology|December 6, 2011
Inherited epidermolysis bullosa: new diagnostic criteria and classificationLizbeth R A Intong, Dédée F Murrell
NPJ Digital Medicine|August 26, 2024
Digital twins in dermatology, current status, and the road aheadHossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell
Frontiers in Medicine|November 21, 2022
Bullous pemphigoid-What do we know about the most recent therapies?Faith A P Zeng, Dedee F Murrell
JAAD International|October 24, 2025
Ofatumumab for the management of refractory pemphigus vulgaris: A case seriesSera Sarsam, Ailin He, Dédée F Murrell
International Journal of Women'S Dermatology|September 4, 2018
Pemphigoid gestationis and intravenous immunoglobulin therapyAnes Yang, Elizabeth Uhlenhake, Dedee F Murrell
Journal of the American Academy of Dermatology|March 19, 2019
Patients left behind: Rare dermatologic conditions miss the orphan drug development boomAfton Chavez, Greg Licholai, Dédée F Murrell
The Australasian Journal of Dermatology|May 24, 2025
The Efficacy of Using Oral Sodium Cromoglycate for Controlling Epidermolysis Bullosa-Related PruritusSera Sarsam, Annabel Stevenson, Dédée F Murrell
Dermatologic Clinics|May 8, 2010
How to take skin biopsies for epidermolysis bullosaLizbeth Ruth A Intong, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Pemphigoid gestationis: pathogenesis and clinical featuresLizbeth R A Intong, Dédée F Murrell
Pageof 49